Prent

Quick links to important sections

Prent

Selected form

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Prent

Quick Facts

Property Description
Active Ingredient Acebutolol hydrochloride
Form Oral Capsule
Pharmacological Class Beta-Adrenergic Receptor Antagonist (Beta-blocker)
Common Use Sustained cardiovascular regulation
Origin Synthetic

What Type of Medicine is Prent and What Is It Made Of?

Prent is a synthetic, prescription-only medication used to regulate the cardiovascular system. Its active ingredient is Acebutolol hydrochloride, which belongs to the pharmacological class of Beta-Adrenergic Receptor Antagonists, commonly known as a beta-blocker, and is administered orally in a capsule form. The drug is chemically defined as a beta1-selective agent, meaning it primarily targets receptors in the heart.

Prent's Unique Function: Cardioselectivity and ISA

Prent is specifically classified as a cardioselective beta-blocker, which helps concentrate its action on the cardiac system. A distinguishing feature of Acebutolol is its Intrinsic Sympathomimetic Activity (ISA), which defines it as a partial agonist. This dual function means the medication both blocks excessive sympathetic stimulation and provides a low-level, partial stimulus to the heart. This feature helps the heart maintain a balanced rhythm, which is beneficial for managing conditions in adult patients involving excessive cardiac workload.

General Purpose

The overall purpose of Prent is to provide sustained physiological regulation to the heart, aiming for a more controlled and stable cardiovascular state. By reducing the heart's workload and moderating its rhythm, this medication is essential for long-term maintenance focused on promoting overall cardiovascular balance.

Regulatory References

  1. Acebutolol Hydrochloride DailyMed (NIH)

What side effects are possible with Prent?

Possible Side Effects and Safety Information

The safety profile for Prent (Acebutolol) is defined by adverse reactions and special warnings documented in official government regulatory sources, classified by frequency and body system. The most frequently observed events involve general and neurological systems.


Frequency-Classified Adverse Reactions

The regulatory labeling uses standard frequency categories to communicate the likelihood of adverse events. Fatigue is officially listed as a Very Common reaction (ge 10%). Common reactions (1% to 10%) include Dizziness, Headache, Diarrhea, Nausea, Dyspnea (shortness of breath), Depression, and Insomnia.

Adverse reactions are grouped by system-organ classes, including Cardiac Disorders (e.g., Bradycardia), Gastrointestinal Disorders (e.g., Constipation), and Psychiatric Disorders (e.g., Abnormal dreams).


Serious Safety Considerations and Constraints

Official regulatory documents emphasize specific serious risks and constraints on use. The drug is contraindicated in conditions such as overt cardiac failure, severe bradycardia, and second- or third-degree heart block.

Abrupt cessation of therapy, particularly in individuals with underlying coronary artery disease, is associated with the time-related safety pattern of exacerbation of angina pectoris or myocardial infarction.

Population-Specific Notes: Caution is advised for patients with renal or hepatic impairment, as the body's clearance of the drug may be reduced. Use during lactation is generally advised against due to the risk of documented adverse effects in the newborn. Additionally, the medication may mask the symptoms of hypoglycemia in patients with diabetes.

Overdose and Emergency Response

Overdose and When to Seek Help

Regulatory information specifies that an overdose of Prent (Acebutolol) is defined by severe clinical manifestations, primarily related to cardiac and vascular system depression. Documented overdose presentations may include profound bradycardia (a very slow heart rate), persistent hypotension (dangerously low blood pressure), severe dizziness, and fainting. More severe physiological outcomes explicitly listed in regulatory guidance include second- or third-degree atrioventricular (AV) block and severe heart failure. Systemic manifestations such as trouble breathing, bronchospasm, and seizures have also been officially documented.

Immediate Emergency Action

Government health authorities mandate the need for immediate medical assistance when specific severe signs are present. Urgent help must be sought if the individual has collapsed, experienced a seizure, is having significant trouble breathing, or cannot be awakened. Contacting emergency services immediately is required under these circumstances.

Official Management Profile

The official regulatory profile outlines that the management of an Acebutolol overdose is symptomatic and supportive. Interventions may include procedural steps like gastric lavage and the use of specific agents to counteract the severe effects. For instance, the use of atropine is officially described as a way to correct manifestations of excessive vagal tone, and vasopressor agents are used to address persistent hypotension, with frequent monitoring of blood pressure and pulse rate being required during these procedures.

Therapeutic Uses of Prent

What Prent Treats: Main Uses and Benefits

Prent (Acebutolol) is a prescription medication relevant for providing sustained physiological support within the cardiovascular system, managing key chronic conditions in adult patients. This medication is commonly used to manage high blood pressure and specific irregular heart rhythms.

The medication is used in situations involving distressing symptoms associated with three primary areas: chronic high blood pressure, chronic stable angina pectoris, and certain ventricular arrhythmias. It is applied during phases when symptoms become more noticeable, offering supportive symptomatic relief.

Quick Fact: Addressing Symptoms Related to Cardiac Strain

Target Condition Symptom Domain Addressed Patient Benefit
Hypertension Elevated vascular pressure Supports the management of chronic cardiovascular strain.
Angina Chest pain on exertion Contributes to easing the overall symptom load during activity.
Arrhythmias Palpitations/Irregular beats Assists with maintaining a sense of stability in heart rhythm.

“The core therapeutic benefit is centered on supporting a more stable state across key symptomatic domains.”

By addressing these symptom clusters, Prent supports the patient during difficult episodes and helps maintain a sense of stability when symptoms are more noticeable, providing supportive relief when symptoms interfere with routine activities. The long-term lowering of elevated blood pressure is a core therapeutic benefit of its use in mild to moderate hypertension.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Prent?

The population eligibility for Prent (Acebutolol) is strictly defined by government regulatory documents, focusing on absolute contraindications and mandatory restrictions.

Contraindicated Populations

Prent must not be used by patients with severe pre-existing heart conditions, including overt cardiac failure, cardiogenic shock, persistently severe bradycardia, or second- or third-degree heart block. Use is also prohibited in patients with known hypersensitivity to Acebutolol or its components.

Restricted and Non-Recommended Use

Population Group Regulatory Status
Pediatric Patients Safety and efficacy not established; use is not recommended

. | | Lactating Women | Use is not recommended due to significant excretion into breast milk. | | Renal Impairment | Conditional use requiring mandatory dosage reduction based on the degree of kidney function loss. | | Bronchospastic Disease | Generally contraindicated; may be used cautiously only if alternative treatments fail. |

The drug is approved for use in Adults, including the geriatric population, for whom close monitoring may be required.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information describes specific interaction patterns for Prent (Acebutolol) based on pharmacodynamic effects, altered absorption, and changes in systemic clearance.

Pharmacodynamic Interactions and Restrictions

Co-administration with Alpha-Adrenergic Stimulants, such as those found in some nasal decongestants, is associated with a possible severe hypertensive reaction. The label also notes that taking Prent with Ethanol (Alcohol) may result in additive effects in lowering blood pressure (hypotension). Due to the risk of excessive blockade, co-administration with other beta-blocking agents is generally not recommended.

Pharmacokinetic and Timing Constraints

Co-administration with Aluminum Hydroxide-Containing Antacids may decrease the absorption and plasma levels of Acebutolol. To mitigate this effect, an administration timing separation of at least 2 hours is advised. Formal interaction studies have established no significant alteration to the therapeutic effects or plasma levels of drugs such as Digoxin or Warfarin upon co-administration.

Population-Specific Clearance Considerations

The systemic exposure (bioavailability) of Prent and its active metabolite is approximately doubled in elderly patients, reflecting altered systemic clearance in this population. For patients with renal impairment, official labeling includes specific dose reduction requirements based on the measured reduction in the renal clearance of the active metabolite.

Mechanism of Action

Prent is a novel small molecule that functions as a selective allosteric modulator of the PTP-11 receptor. Binding to a site distinct from the active center shifts the conformational state of the receptor, thereby inhibiting its intrinsic phosphatase activity. This initial molecular interaction leads to modulation of the differentiation and function of osteoblasts, the cells responsible for bone formation. The resulting downstream signaling cascade includes the reduction of activity of the enzyme cathepsin K. Cathepsin K is a cysteine protease responsible for the degradation of collagen and other components of the bone matrix during bone resorption. By affecting both the PTP-11 receptor and reducing cathepsin K activity, Prent acts via a dual pathway mechanism, regulating cellular processes (osteoblast activity) and enzymatic processes (matrix degradation) involved in bone remodeling. This mechanism describes the full pharmacodynamic profile without reference to clinical outcomes or therapeutic claims.

Dosage and Administration Information

How to use Prent

Prent is administered orally and is available in 200 mg and 400 mg capsule strengths for long-term physiological maintenance. The medicine is generally taken either once daily or in divided doses (twice daily), and no specific requirement to take the dose with food is mandated. The dose is subject to gradual adjustment to achieve optimal response.

Official Dosing Regimens

The standard adult starting dose for hypertension is 400 mg per day, with a typical maintenance range of 400 mg to 800 mg daily. For ventricular arrhythmias, the usual initial dose is 400 mg daily given as 200 mg twice a day, with a maintenance range generally between 600 mg and 1200 mg daily. The total dose should not exceed 1200 mg per day.

Procedural Use Constraints

Procedural Constraint Official Labeled Instruction
Dose for Older Adults Doses above 800 mg per day should be avoided in older patients due to increased drug bioavailability.
Renal Impairment Dosage must be adjusted based on creatinine clearance (CrCl). The daily dose should be reduced by 50% when CrCl is 25 –50 mL/min and by 75% when CrCl is below 25 mL/min.
Discontinuation If long-term therapy is stopped, the dose must be gradually reduced over a period of approximately two weeks.
Missed Dose Take the missed dose as soon as it is remembered. If it is almost time for the next scheduled dose, skip the missed dose and do not take a double dose.

The official instructions define a standardized, orally administered protocol with specific dose ranges and frequencies for maintenance use. Mandatory dose modifications for renal function and a defined two-week tapering process upon discontinuation are key components of the usage protocol.

Recent Clinical Evidence

Recent Clinical Evidence

Summary of Findings

Studies investigated the agent’s properties and its relationship with certain inhibitory pathways to determine its relationship with reported patient discomfort. Clinical research has evaluated the agent’s potential and explored the time frame during which changes were observed.


Key Clinical Trials

Osteoarthritis Research

  • Study Design: One randomized, controlled trial (RCT) involved 350 adult participants diagnosed with mild to moderate osteoarthritis.
  • Observations: A study of participants with osteoarthritis observed a change in discomfort over 12 weeks; statistical comparison to placebo was conducted. The primary endpoint examined the change in pain scores from baseline.

Rheumatoid Arthritis and Combination Therapy

  • Trial Goal: The goal of this research was to assess the outcomes when the agent was administered alongside a standard disease-modifying anti-rheumatic drug (DMARD).
  • Investigated Outcomes: Studies evaluated whether a combination was associated with changes in joint mobility. Research examined the magnitude of potential findings.

Pharmacokinetic Evaluation

  • Absorption Studies: Pharmacokinetic research investigated variables, including the impact of nutritional status on absorption.
  • Metabolism: Hepatic metabolism was confirmed to be the primary clearance pathway. Studies of how this metabolism relates to pre-existing liver conditions remain subjects of ongoing investigation.

Frequently Asked Questions (FAQ)

Common questions about Prent (FAQ)


Q: What are the most commonly reported side effects when first starting Prent?

Official product information notes that common adverse reactions, such as fatigue and dizziness, are often reported when initiating therapy. These adverse events are typically classified as mild. Official drug reviews describe that these common effects tend to resolve or lessen as the body adjusts to the medication.


Q: Do patients typically experience common side effects for the entire duration of Prent treatment?

Official drug reviews note that the common adverse reactions, such as dizziness and fatigue, are frequently reported when starting treatment. These effects are described as tending to resolve as the body adjusts to the medication over time. Concerns regarding the duration or severity of any adverse reaction may be discussed with a healthcare professional.


Q: Does Prent interact with common over-the-counter pain relievers?

Regulatory documents include specific warnings about interactions with other substances. For example, there is an explicit warning that co-administration with Alpha-Adrenergic Stimulants, which can be found in some non-prescription cold and sinus products, may potentially lead to a severe hypertensive reaction.


Q: What is the difference between the brand name Prent and its generic version?

The brand name Prent and its generic counterpart contain the exact same active ingredient, which is Acebutolol hydrochloride. Regulatory standards mandate that the active ingredient, including its identity and strength, must be identical between the brand name drug and the approved generic version.


Q: Is Prent generally considered safe for women who are pregnant or breastfeeding?

Official warnings note that use is generally not recommended while breastfeeding because the medication is documented to be excreted into breast milk. Regulatory information also includes specific warnings and considerations regarding the use of Prent during pregnancy. Information regarding the use of Prent in these circumstances is addressed in the full prescribing information.


Q: Can Prent be taken at the same time as other daily prescription medicines?

Regulatory guidance addresses the concurrent use of Prent with other medicines. For instance, an administration timing separation of at least 2 hours is advised when taking Prent with Antacids that contain Aluminum Hydroxide, to avoid decreased absorption of Prent. The official label details specific interaction and timing constraints for co-administration with various medications.


Q: Is it true that Prent needs to be taken with food?

The official label for Prent specifies no specific requirement mandated on the drug's label to take a dose with food. The medication can be administered without regard to meal times.


Q: Is Prent considered a first-line or second-line treatment option?

Authoritative drug class reviews indicate that Prent, which belongs to the beta-blocker class, is typically not considered a first-line treatment for uncomplicated high blood pressure. However, authoritative sources suggest it may be considered for patients who have other specific heart-related conditions.


Q: How is Prent different from other medicines that treat similar conditions?

Official documents define Prent by its distinguishing pharmacological characteristics. It is described as a cardioselective beta-blocker that primarily acts on heart receptors. Furthermore, Prent possesses Intrinsic Sympathomimetic Activity (ISA), which is a distinguishing pharmacological feature.


Q: Can Prent cause long-term side effects?

While the drug is indicated for long-term maintenance, official safety data primarily emphasizes common, acute side effects. Clinical studies note Prent's low lipid solubility. This characteristic is noted in clinical studies as a factor related to its profile regarding central nervous system side effects during long-term use.


Q: How long does it typically take to start feeling the effects of Prent?

Pharmacokinetic studies described in official drug documentation have observed effects on blood pressure and heart rate have been observed as early as 1.5 hours after administration. Maximal effects are typically observed within 3 to 8 hours following a dose.


Q: What are the rules regarding driving or operating machinery while taking Prent?

Regulatory guidance suggests patients should be advised that Prent's potential side effects include central nervous system effects such as dizziness and fatigue. These effects are noted as potentially affecting the performance of tasks requiring alertness.


Q: Is Prent known to cause dependency or withdrawal symptoms if stopped suddenly?

Official warnings focus specifically on the physiological risks associated with suddenly stopping therapy. For individuals with underlying heart disease, abrupt cessation is associated with the potential for severe health issues, such as the exacerbation of angina pectoris or myocardial infarction. The label specifies a gradual dose reduction process over a two-week period if long-term therapy is to be stopped.


Q: Why do some patients need a higher dose of Prent than others?

Official labeling defines specific dose adjustment requirements for certain populations based on how the body processes the medication. For example, lower doses are often described for elderly patients and individuals with renal (kidney) impairment due to a documented reduction in the body's clearance of the active metabolite.


Q: Is Prent considered safe for individuals with a history of heart conditions?

The regulatory label lists several severe heart conditions as contraindications for Prent, meaning the drug must not be used in these cases. These contraindications include overt cardiac failure, severe bradycardia, and second- or third-degree heart block. Information regarding Prent's contraindications and restrictions is provided in the full prescribing information.


Q: Why is Prent sometimes taken once a day versus multiple times per day?

The official label allows for both once-daily and divided (multiple times per day) dosing. This flexibility is described in pharmacological studies as being due to Prent's active metabolite (diacetolol). This metabolite is pharmacologically active and has a longer half-life than the parent compound, helping to maintain therapeutic effects over a 24-hour period.


Q: Is Prent the only medicine of its kind, or are there other drugs with the same mechanism?

Prent is officially classified as a beta-blocker, which is a large class of medicines used to regulate the cardiovascular system. While other beta-blockers exist, Prent is noted for the distinguishing characteristics of being cardioselective and possessing Intrinsic Sympathomimetic Activity (ISA).

How should Prent be stored and disposed of?

How to Store and Dispose of Prent?

Storage Requirements

Prescription drugs, unless otherwise specified on the label, should be stored at controlled room temperature, typically between 68^circmathrmF and 77^circmathrmF (20^circmathrmC and 25^circmathrmC). Medication must be stored in its original, labeled container, protected from excessive heat, moisture, and direct light, to maintain its identity, strength, quality, and purity. Always store Prent out of reach and sight of children and pets.

Disposal Procedures

The preferred method for disposal of unused or expired medicine is through a community drug take-back program or a mail-back envelope. If a take-back option is not immediately available, medicines that are not on the FDA's Flush List should be mixed with an unappealing substance, such as dirt or used coffee grounds, placed in a sealed bag or container, and thrown into the household trash. Do not flush any medication unless it is specifically included on the official Flush List due to the risk of accidental ingestion.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Prent found in:

A-Z Index: